Abstract
Introduction:
In disease-endemic areas, the annual incidence of enteric fever is about 1%. Peak incidence is seen in children 5-15 years of age; but in regions where the disease is highly endemic, as in India, children younger than 5 years of age may have the highest infection rates i .
Enteric fever includes typhoid and paratyphoid fever. Typhoid fever is caused by a Gramnegative bacilli, Salmonella enterica subspecies entericaserovarTyphi (Salmonella typhi), whereas paratyphoid fever is caused by any of the three serovars of Salmonella enterica subspecies enterica, namely S. paratyphi A, S. schottmuelleri (also called S. paratyphi B), and S. hirschfeldii (also called S. paratyphi C). World wideType A is the most common pathogen worldwide, whereas Type B predominates in Europe. Type C is rare, and is seen only in the Far East. The overall ratio of the disease caused by S. typhi to that caused by S. paratyphi is about 10 :1 ratio ii .
There are about 22 million new typhoid cases occur each year. Young children in poor, resourcelimited areas, who make up the majority of the new cases and there is a mortality figures of 215,000 deaths annually iii .
A systemic infection caused by Salmonella entericasubspecies enterica serovarstyphi (S typhi) and paratyphi (S paratyphi) is known as enteric fever. The disease is endemic in India with an incidence ranging from 102 to 2219 per 100,000 population.
iv In developing countries like India, typhoid fever is a common illness. v A sharp decline in the rates of complications and mortality due to typhoid fever is observed as a result of introduction of effective antibiotic therapy since 1950s.
vi MDR-ST became endemic in many areas of Asia, including India soon after multidrug-resistant strains of Salmonella enterica serotype typhi (MDR-ST) that were resistant to all the three first-line drugs then in use, namely chloramphenicol, amoxycillin and co-trimoxazole emerged in early 1990s.
vii Fluoroquinolones are currently the first-line drug for the treatment of enteric fever. It is found that fluoroquinolones are very effective against MDR-ST, with cure rates more than 96% and fever clearance achieved in less than four days.
viii It was observed that fever took longer than before to clear, and at times surprisingly failed to respond to ciprofloxacin therapy towards the end of last decade.
ix Strains of S. typhi are resistant to nalidixic acid and an inferior clinical response to fluoroquinolones was noted in patients infected with nalidixic acid-resistant S. typhi (NARST) compared to response in those infected with nalidixic acidsensitive S. typhi (NASST) strains.
x An increase in prevalence of Nalidixic Acid Resistant Salmonella (NARS) in India has been observed. Fluroquinolone resistance is predicted by Nalidixic acid resistance. xi Present study was carried out toexplore and evaluate antimicrobial susceptibility pattern in culture positive cases.
MATERIAL AND METHODS:
This was a retrospective study was conducted in the Dept. of Medicine in collaboration with Dept. of Microbiology. The patients admitted with enteric fever at Ananta Institute of Medical Science and Research Centre Rajsamand.
Only blood culture or bone marrow culture positive cases were included. The patients with culture isolated enteric fever were included in the study.
Antimicrobial susceptibility testing was carried out by disk diffusion method using antibiotic discs for chloramphenicol (30 μg), amoxicillin (10 μg Statistical analysis was done by using SPSS software. An excel sheet was used to analyse data extracted from the case sheets. P value of < 0.05 was considered as statistically significant.
RESULTS:
A total of 82 culture positive cases were included in the present study NS: Not significant, CI: Confidence Interval 80 culture isolates were from blood culture and 2 from the bone marrow culture. Salmonella entericasubspecies enterica serovartyphi (S typhi) was isolated from 67 (81.70%) patients while Salmonella enterica subspecies entericaserovarparatyphi (S paratyphi A) was isolated from 13 (15.85%) cases and 2 (2.44%) were Salmonella enterica subspecies entericaserovarschottmuelleri (S paratyphiB). All blood cultures positive with a mean of 6.8 days after the onset of fever. In our study it is observed that 79.3% isolates were resistant to Ciprofloxacin al whereas 20.7% were resistant to Nalidixic acid in contrast to 1.6% resistant to Ciprofloxacin and 57% resistant to Nalidixic acid in a study conducted by Upadhyay R et.al . Joshi RD et al demonstrated co-trimoxazole, chloramphenicol, ceftriaxone, cefotaxime, cefixime, and ofloxacinas 100% sensitive. Similarly, amoxicillin sensitivity was 98.1% (n=156) while ciprofloxacin was sensitive in 6.3% (n=10), intermediately sensitive in 49.1% (n=78) and resistance in 44.7% (n=71).The newer quinolone levofloxacin showed 78.5% (n=11) sensitivity.
Azithromycin was sensitive in 99.2% (n=132) of total isolated Salmonella species both typhi and paratyph 13 .The susceptibility to ciprofloxacin was 
CONCLUSION
In a culture positive cases 65(79.3%) isolates were resistant to ciprofloxacin and 17 (20.7%) were resistant to nalidixic acid. Multidrug resistant isolates were 65(79.3%). A high degree of sensitivity was noted to chloramphenicolshowing sensitivity has returned to conventional antibiotics which were not used commonly by the physicians in recent years.
